ANIXA BIOSCIENCES, INC. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock
ANIXA BIOSCIENCES, INC. (ANIX) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock of 461.07 thousand shares for the 6-month period ending 2015-04-30, per its 10-Q filed 2016-05-20.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock · last filed 2016-05-20
- ANIXA BIOSCIENCES, INC. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2015-01-31 was 461.57K shares.
- ANIXA BIOSCIENCES, INC. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2014-07-31 was 739.96K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 3 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 6 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 6 month as first filed |
|---|---|---|---|---|
| 2015-04-30 | 461.07K shares 10-Q · filed 2016-05-20 | 11.53M shares 10-Q · filed 2015-05-22 | ||
| 2015-01-31 | 461.57K shares 10-Q · filed 2016-02-19 | 11.54M shares 10-Q · filed 2015-03-09 | ||
| 2014-07-31 | 739.96K shares 10-Q · filed 2015-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |